BONESUPPORT™ APPOINTS ANNA STEGMARK EVP QM & RA

BONESUPPORT AB a leading company in orthobiologics for the management of bone injuries, today announces that Anna Stegmark has been appointed EVP Quality Management & Regulatory Affairs with effect from 1 July 2024. She will also be part of the management team.

Anna Stegmark’s professional career comprises more than 19 years in the medical device sector, leading global quality and regulatory teams since 2010. Most recently, she was with Radiometer Medical as Director QA Operation.

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 591 million in 2023. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Datum	2024-06-12, kl 12:15
Källa	MFN

Bifogade filer

BONESUPPORT™ APPOINTS ANNA STEGMARK EVP QM & RA

Affiliate

Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID

Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet

LOGGA IN

Bonesupport

BONESUPPORT™ APPOINTS ANNA STEGMARK EVP QM & RA

Affiliate

Cookie-samtycke

Anpassa dina cookie-inställningar